Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
This item clarifies what constitutes the fee schedule for the Dividend Aristocrats Etf and how each fee contributes to total costs.
11,557 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A surge in people choosing to rent is changing the game for real estate investors. This article breaks down loan stra...
Headwinds have pressured Vornado, but two strategic catalysts could unlock meaningful upside. This guide breaks down ...
Curious if you can win the lottery of Social Security—that $5,251-a-month top payout in 2026? It hinges on work credi...
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
A new moisture-absorbing paint-and-primer system backed by large homebuilders is entering the market, promising to re...
As energy demand grows—from data centers to next-gen reactors—centrus energy stock potential captures the imagination...
Lenders are tightening terms on construction loans in early 2026, forcing builders to reevaluate finance leadership. ...
AI-driven data centers are reshaping the power grid, with Pennsylvania at the heart of the shift. New investments, wo...
The u.s. women’s hockey team is headed to Las Vegas this July for a celebratory weekend hosted by Flavor Flav, signal...
In a crowded rental market, choosing where to list can make or break how fast you find tenants. This guide breaks dow...
A high-profile moment shows how a single statement can ripple into your wallet. This article breaks down the financia...